603658 Autobio Diagnostics
- 40.55
- -1.19-2.85%
Autobio Diagnostics News
Announcement from Autobio Diagnostics regarding obtaining medical instrument registration certificate.
Legal Opinion of Shanghai AllBright Law Firm on Antu Biotech's 2023 Differential Dividend
Antu Biotech Investor Relations Activity Record Form (May 20, 2024)
Antu Biotech's announcement on holding a performance briefing for the first quarter of 2023 and 2024
Antu Biotech's announcement on the use of idle funds raised for cash management and redemption
Antu Biotech Investor Relations Activity Record Form (April 19, 2024)
Verification Report on the Deposit and Use of Funds Raised by Antu Biotech in 2023
Rules of procedure for the Antu Biotech Shareholders' Meeting (revised in April 2024)
Antu Biotech Related Transaction Decision System (Revised in April 2024)
Antu Biotech Foreign Exchange Hedging Business Management System (established in April 2024)
Antu Biotech\'s announcement on changes in accounting policies
Announcement of Resolutions of the 13th Meeting of the 4th Board of Supervisors of Antu Biotech
2023 Antu Biotech Social Responsibility Report
Antu Biotech's announcement on the renewal of the company's 2024 audit agency
Special explanation on the use of capital by Antu Biotech's controlling shareholders and other related parties
Announcement of Resolutions of the 15th Meeting of the 4th Board of Directors of Antu Biotech
Special Opinions on Independent Directors' Independence Self-Inspection in 2023
On the 2023 Performance Evaluation Report of Accounting Firms
Special Report on the Deposit and Actual Use of Funds Raised by Antu Biotech in 2023
Antu Biotech Independent Director Work System (Revised in April 2024)
Analysis
Price Target
No Data
